We have located links that may give you full text access.
English Abstract
Journal Article
[Long-term outcome of repeat percutaneous balloon mitral valvuloplasty in patients with mitral restenosis].
Zhonghua Xin Xue Guan Bing za Zhi 2009 January
OBJECTIVE: To observe the long-term outcome of repeat percutaneous balloon mitral valvuloplasty (PBMV) in patients with mitral restenosis.
METHODS: Thirty-nine patients with mitral restenosis post fist PBMV received repeat PBMV with the improved Inoue method. Patients were followed up for 12 to 146 months.
RESULTS: Repeat PBMV succeed in 36 out of 39 patients (92.3%). Immediately after repeat PBMV, clinical symptoms and left atrial mean pressure [LAP, (24.50+/-6.54) mm Hg (1 mm Hg=0.133 kPa) vs. (9.66+/-4.21) mm Hg], pulmonary artery systolic pressure [PASP, (58.12+/-12.68) mm Hg vs. (31.45+/-10.02) mm Hg], mitral valve gradient [MVG, (17.03+/-4.52) mm Hg vs. (7.79+/-4.07) mm Hg] and area of mitral valve orifice [MVA, (1.05+/-0.19) cm2 vs. (2.23+/-0.22) cm2] improved significantly compared to pre-PBMV (all P<0.05). Left atrial end-diastolic dimension (LAD) remained unchanged post operation [(4.71+/-0.75) cm vs. (4.07+/-0.69) cm, P>0.05]. Thirty six out of 39 cases could be followed up for a period between 12-146 months (69+/-23) months. Follow-up, data showed that MVA [(2.02+/-0.21) cm2 vs. (2.23+/-0.22) cm2] and MVG [(9.15+/-4.11) mm Hg vs. (7.79+/-4.07) mm Hg] were similar as those directly post operation (all P>0.05). Cardiac function and quality of life were also significantly improved in most patients during follow up.
CONCLUSION: Repeat PBMV is safe and effective for most patients with mitral restenosis.
METHODS: Thirty-nine patients with mitral restenosis post fist PBMV received repeat PBMV with the improved Inoue method. Patients were followed up for 12 to 146 months.
RESULTS: Repeat PBMV succeed in 36 out of 39 patients (92.3%). Immediately after repeat PBMV, clinical symptoms and left atrial mean pressure [LAP, (24.50+/-6.54) mm Hg (1 mm Hg=0.133 kPa) vs. (9.66+/-4.21) mm Hg], pulmonary artery systolic pressure [PASP, (58.12+/-12.68) mm Hg vs. (31.45+/-10.02) mm Hg], mitral valve gradient [MVG, (17.03+/-4.52) mm Hg vs. (7.79+/-4.07) mm Hg] and area of mitral valve orifice [MVA, (1.05+/-0.19) cm2 vs. (2.23+/-0.22) cm2] improved significantly compared to pre-PBMV (all P<0.05). Left atrial end-diastolic dimension (LAD) remained unchanged post operation [(4.71+/-0.75) cm vs. (4.07+/-0.69) cm, P>0.05]. Thirty six out of 39 cases could be followed up for a period between 12-146 months (69+/-23) months. Follow-up, data showed that MVA [(2.02+/-0.21) cm2 vs. (2.23+/-0.22) cm2] and MVG [(9.15+/-4.11) mm Hg vs. (7.79+/-4.07) mm Hg] were similar as those directly post operation (all P>0.05). Cardiac function and quality of life were also significantly improved in most patients during follow up.
CONCLUSION: Repeat PBMV is safe and effective for most patients with mitral restenosis.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app